Clinical Trials · NCT02545738
Antiproteinuric Effects of Liraglutide Treatment
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Enrollment
- 32
- Start date
- Apr 2015
- Locations
- 1 site, Denmark
- Primary endpoint
- Change in albuminuria